Biotech · Private company
Radiomedix, Inc.
Track this companyFree. Adds Radiomedix, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 64Cu-DOTATATEPhase 3 · Neuroendocrine TumorsClinicalTrials.gov · fetched Nov 12, 2026
- 203Pb-RMX-VHPIB injectionPhase 1 · Glioblastoma Multiforme (GBM)ClinicalTrials.gov · fetched Nov 12, 2026
- SPECT/CT ImagingPhase 1 · Glioblastoma Multiforme (GBM)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)PHASE1 · RECRUITING · started Aug 15, 2026ClinicalTrials.gov NCT07733674 · fetched Nov 12, 2026
- Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATEPHASE3 · COMPLETED · started Aug 23, 2018ClinicalTrials.gov NCT03673943 · fetched Nov 12, 2026
- 68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)NA · COMPLETED · started Mar 1, 2013ClinicalTrials.gov NCT01879657 · fetched Nov 12, 2026
- Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine TumorsPHASE2_PHASE3 · COMPLETED · started Aug 1, 2005ClinicalTrials.gov NCT00442533 · fetched Nov 12, 2026